Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Clinical trial NCT07142551 · RECRUITING

Trial details

NCT number: NCT07142551
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2026-03-09
Primary completion: 2030-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.